Atrovent 20 micrograms pressurized inhalation solution

Atrovent is a well-known brand of ipratropium bromide, a bronchodilator used to treat conditions such as asthma and chronic obstructive pulmonary disease (COPD). The brand was originally developed and launched by the German pharmaceutical company Boehringer Ingelheim, which remains its ultimate owner. Founded in 1885 in Ingelheim am Rhein, Germany, Boehringer Ingelheim is one of the world's largest private pharmaceutical companies and is still owned by the founding families (Boehringer, Liebrecht, and von Baumbach).

Manufacturing of Atrovent occurs in several locations worldwide to meet global demand, with significant facilities in Germany and Spain (Boehringer Ingelheim España, S.A.). In specific markets like Spain, the product is distributed and managed by local subsidiaries such as Boehringer Ingelheim España. As of 2026, the company continues to operate as an independent, family-owned biopharmaceutical leader focused on respiratory, cardiovascular, and metabolic health.